Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Methylprednisolone × Clear all

NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Phase 3 Completed

Neoplasm Metastasis, Prostatic Neoplasms

NCT00003682 2016-06-23

Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms